Capricor Class Action Lawsuit: A Complete Guide on Shareholder Rights [2025]

The Capricor class action lawsuit seeks to represent purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between October 9, 2024 and July 10, 2025, inclusive (the “Class Period”).  Captioned Leong v. Capricor Therapeutics, Inc., No. 25-cv-01815 (S.D. Cal.), the Capricor class action lawsuit charges Capricor and Capricor’s CEO with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Capricor class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected].

Lead plaintiff motions for the e Capricor class action lawsuit must be filed with the court no later thanSeptember 15, 2024.

Understanding Securities Fraud Class Action Lawsuits

Securities fraud class action lawsuits represent a significant legal mechanism for investors who have suffered financial losses due to corporate malfeasance. These lawsuits, such as the Capricor class action lawsuit, typically arise when a company or its executives engage in deceptive practices that mislead investors about the company’s financial health or prospect.

The goal of such litigation is to hold the perpetrators accountable and secure compensation for the affected investors. Securities fraud encompasses a range of activities, including insider trading, false financial statements, and misleading disclosures, all of which can severely impact market integrity and investor confidence.

In a class action context, a group of investors collectively brings the lawsuit against the defendant, which could be a corporation or its executives. This collective approach is particularly powerful in the securities realm because it allows individual investors, who might not have the resources to pursue litigation on their own, to band together and seek justice.

The class action mechanism ensures that the legal process is efficient and that the interests of all affected investors are represented.

The complexity of securities fraud class action lawsuits requires plaintiffs to navigate a labyrinth of legal standards and procedural hurdles. One of the most significant challenges is surviving a motion to dismiss, a legal maneuver by the defendants to have the case thrown out before it reaches trial.

Understanding the nuances of the Capricor lawsuit is crucial for any stakeholder involved, as it sets the stage for the strategic decisions that will follow. In the case of the Capricor class action lawsuit, these elements come into sharp focus, highlighting the importance of a well-crafted legal strategy.

Allegations in the Capricor Class Action Lawsuit

Capricor is a clinical-stage biotechnology company that engages in the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”) and other diseases.

The Capricor class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose adverse facts concerning its four-year safety and efficacy data from its Phase 2 HOPE-2 trial study and gave the false impression that Capricor could obtain first approval for DMD cardiomyopathy.

TheCapricor class action lawsuit further alleges that on May 5, 2025, Capricor announced it had completed its mid-cycle review meeting with the U.S. Food and Drug Administration (“FDA”) on deramiocel for the treatment of DMD and that no significant deficiencies were identified by the Review Committee and that the package is on track for a Prescription Drug User Fee Act action date of August 31, 2025.  According to the complaint, the FDA also confirmed its intent to hold an advisory committee meeting.  The Capricor class action lawsuit alleges that on this news, the price of Capricor stock fell more than 29%.

The Capricor class action lawsuit further alleges that on June 20, 2025, Stat News reported that Vinjay Prasad, the director of the FDA’s Center for Biologics Evaluation and Research, canceled the advisory committee meeting regarding deramiocel due to being “skeptical of the treatment” and uncertain about the drug’s efficacy and safety.  On this news, the price of Capricor stock fell more than 30%, according to the complaint.

Then, on July 11, 2025, the Capricor class action lawsuit also alleges that Capricor announced it received a Complete Response Letter from the FDA denying Capricor’s Biologics License Application for deramiocel, citing it did not meet the statutory requirement for substantial evidence of effectiveness and the need for additional clinical data.  On this news, the price of Capricor stock fell nearly 33%, according to the complaint.

The Role of Shareholders in Class Action Lawsuits

Shareholders play a crucial role in class action lawsuits, as they collectively seek justice against corporations that may have engaged in fraudulent activities. In the context of the Capricor lawsuit affected investors have the opportunity to join the class action and potentially recover their losses.

Rights of Shareholders

Understanding shareholder rights is essential for anyone involved in the Capricor class action lawsuit. Common rights include:

• Voting Rights: Shareholders have the right to vote on significant corporate matters, including mergers and acquisitions.
• Right to Information: Investors are entitled to receive accurate and timely information about the company’s financial performance and operations.
• Right to Sue: Shareholders can take legal action against the company or its executives for breaches of fiduciary duty or other misconduct.

Importance of Activism

Shareholder activism is a vital aspect of corporate governance. When investors believe that a company is not acting in their best interests, they have the right and responsibility to voice their concerns. This activism can take various forms, including voting against management proposals, engaging in dialogue with the board, or participating in class action lawsuits like the one against Alto Neuroscience.

The Process of Joining the Capricor Class Action Lawsuit

For investors who suffered losses due to the alleged misconduct of Lineage, joining the class action lawsuit can be a viable option. Here’s how the process typically works:

Eligibility Criteria

To be eligible to participate in the Capricor class action lawsuit investors must meet specific criteria:

• Purchase of Shares: Investors must have purchased Lineage common stock during the class period, which is defined as anuary 5, 2023 and June 3, 2025, inclusive.
• Sustained Losses: Affected shareholders must demonstrate that they incurred financial losses as a result of the alleged fraudulent activities.

Steps to Join

1. Consult Legal Counsel: It is advisable for investors to seek legal advice to understand their rights and options.
2. File a Lead Plaintiff Motion: If an investor wishes to take on a more active role, they can file a motion to be appointed as the lead plaintiff in the class action.
3. Stay Informed: Investors should monitor the progress of the lawsuit and any developments that may affect their claims.

The Implications of the Capricor Lawsuit

The outcome of the Capricor class action lawsuit could have far-reaching implications for both the company and its shareholders.

Potential Consequences for Capricor

If the plaintiffs succeed in their claims, Lineage may face significant financial penalties, including:

• Monetary Damages: The company could be required to compensate affected shareholders for their losses.
• Reputational Damage: A ruling against Lineage could tarnish its reputation and impact investor confidence.

Impact on Shareholders

For shareholders, the lawsuit represents an opportunity to seek redress for their losses. Successful litigation could result in:

• Financial Compensation: A favorable outcome may lead to monetary recovery for investors who suffered losses.
• Increased Accountability: The lawsuit may prompt Lineage to improve its corporate governance practices and enhance transparency.

The Importance of Evidence in Class Action Lawsuits

In any class action lawsuit, evidence plays a critical role in substantiating claims. For the Capricor lawsuit, gathering and organizing relevant evidence is essential for building a compelling case.

Types of Evidence

Investors should focus on collecting various forms of evidence, including:

• Financial Documents: This includes annual reports, financial statements, and any communications from the company that may demonstrate misrepresentation.
• Correspondence: Emails or other communications that indicate a lack of transparency or misleading information can be crucial.
• Market Analysis: Data showing the stock price fluctuations and the impact of the alleged misconduct on shareholder value.

The Role of Legal Counsel

Engaging with experienced legal counsel is vital for navigating the complexities of the Capricor lawsuit. Attorneys can provide guidance on evidence collection, legal strategy, and the overall litigation process.

Monitoring the Progress of the Capricor Class Action Lawsuit

Staying informed about the developments in the Capricor class action lawsuit is crucial for affected shareholders.

Key Milestones to Watch

Investors should pay attention to several key milestones, including:

• Court Rulings: Significant decisions made by the court can impact the direction of the lawsuit.
• Settlement Negotiations: Discussions regarding potential settlements may arise, providing an opportunity for affected shareholders to recover losses.
• Changes in Legal Landscape: Any shifts in securities law or regulations could influence the case’s outcome.

Communication with Legal Counsel

Maintaining open lines of communication with legal representatives is essential for shareholders. Attorneys can provide updates on case developments and help investors understand the implications of each new piece of information.

The Future of Shareholder Rights

The Capricor class action lawsuit underscores the importance of shareholder rights in the corporate landscape. As investors become more aware of their rights and responsibilities, the demand for transparency and accountability in corporate governance will likely increase.

Evolving Legal Landscape

The legal framework surrounding shareholder rights is continually evolving. Recent trends indicate a growing emphasis on:

• Corporate Accountability: Companies are increasingly held accountable for their actions, particularly in cases of alleged fraud or misconduct.
• Investor Activism: Shareholders are becoming more vocal and active in advocating for their rights, leading to changes in corporate governance practices.

The Role of Education

Educating investors about their rights and the legal mechanisms available to them is crucial. Resources such as investor protection organizations and legal counsel can empower shareholders to take action when necessary.

Conclusion

The Capricor class action lawsuit represents a significant moment for shareholders who have suffered losses due to alleged corporate misconduct. By understanding their rights and the legal processes involved, investors can take proactive steps to seek justice and hold companies accountable. As the legal landscape continues to evolve, the importance of shareholder activism and corporate governance will remain paramount in protecting investor interests.

This article provides a comprehensive overview of the Capricor class action lawsuit and the rights of shareholders. By synthesizing key insights and presenting them in a clear and engaging manner, it aims to inform and empower investors navigating this complex legal landscape.